{"id":"W4290993146","doi":"10.1016/j.esmoop.2022.100553","title":"Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer","year":2022,"lang":"en","type":"review","venue":"ESMO Open","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Lilly Deutschland; Merck Sharp and Dohme; Eisai; Clovis Oncology; Boehringer Ingelheim; Ariad Pharmaceuticals; Roche; Daiichi-Sankyo; Teva Pharmaceutical Industries; Novartis; Merck; Sanofi-Aventis Deutschland; Pfizer; Queen Mary University of London; Bristol-Myers Squibb; AstraZeneca; Gilead Sciences","keywords":"Medicine; Breast cancer; Trastuzumab; Internal medicine; Pneumonitis; Nausea; Context (archaeology); Neutropenia; Oncology; Metastatic breast cancer; Cancer; Chemotherapy; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002458106,0.0003377872,0.002812876,0.0002626626,0.00004135132,0.00002392386,0.0008752805,0.0001769229,0.004629404],"category_scores_gemma":[0.0001090413,0.0002690715,0.0004559297,0.0007494318,0.0001146076,0.0001028073,0.0009208563,0.0007353676,0.0000157712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002138154,"about_ca_system_score_gemma":0.00245074,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01186452,"about_ca_topic_score_gemma":0.0003988281,"domain_scores_codex":[0.9956962,0.0008122235,0.001702194,0.0006552492,0.0007540502,0.0003800311],"domain_scores_gemma":[0.9973365,0.0006869261,0.0007745457,0.0009471959,0.00008995891,0.0001648552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003115443,0.001241117,0.0001032527,0.01518511,0.001460196,0.0005411782,0.0001658602,0.000008033049,1.997642e-8,0.00006925586,0.0006479766,0.9802665],"study_design_scores_gemma":[0.00188507,0.0007439989,0.0004386806,0.01976031,0.001989349,0.000134647,0.0004294974,0.000004939666,0.000001049353,0.00000301745,0.9744275,0.0001819423],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001432475,0.9530732,0.000005267023,0.0004622609,0.0002583239,0.005366974,0.0002337857,0.00001009536,0.04057577],"genre_scores_gemma":[0.00003649796,0.9909278,0.004930607,0.00005577772,0.0001000559,0.001921201,0.00009167146,0.00008297277,0.001853478],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9800845,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3380420165733111,"score_gpt":0.5932876732972931,"score_spread":0.2552456567239821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}